Celldex Therapeutics (CLDX) Q2 2014 Results - Earnings Call Webcast

Aug. 6.14 | About: Celldex Therapeutics, (CLDX)

Celldex (NASDAQ:CLDX): Q2 EPS of -$0.32 in-line. Revenue of $0.6M (+500.0% Y/Y)

The following audio is from a conference call that will begin on August 06, 2014 at 16:30 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.